Baricitinib as the treatment of choice for hospitalised individuals with COVID-19 by Peter J. Richardson, Justin Stebbing

Get full text

Impact of the Delay Period between Electrochemical Hydrogen Charging and Tensile Testing on the Mechanical Properties of Mild Steel by Igor A. Chaves, Peter J. Richardson, Sam Lynch, Jessica A. Allen

Get full text

The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19 by Peter J. Richardson, Bruce W. S. Robinson, Daniel P. Smith, Justin Stebbing

Get full text

The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma by Giovanni Luca Gravina, Andrea Mancini, Francesco Marampon, Alessandro Colapietro, Simona Delle Monache, Roberta Sferra, Flora Vitale, Peter J. Richardson, Lee Patient, Stephen Burbidge, Claudio Festuccia

Get full text

Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis by Peter J. Richardson, Daniel P. Smith, Alex de Giorgio, Xenia Snetkov, Joshua Almond-Thynne, Sara Cronin, Richard J. Mead, Christopher J. McDermott, Pamela J. Shaw

Get full text

Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients by Justin Stebbing, Venkatesh Krishnan, Stephanie de Bono, Silvia Ottaviani, Giacomo Casalini, Peter J Richardson, Vanessa Monteil, Volker M Lauschke, Ali Mirazimi, Sonia Youhanna, Yee‐Joo Tan, Fausto Baldanti, Antonella Sarasini, Jorge A Ross Terres, Brian J Nickoloff, Richard E Higgs, Guilherme Rocha, Nicole L Byers, Douglas E Schlichting, Ajay Nirula, Anabela Cardoso, Mario Corbellino, the Sacco Baricitinib Study Group

Get full text